Literature DB >> 10749304

DDAVP to prevent rapid correction in hyponatremia.

M A Goldszmidt1, E A Iliescu.   

Abstract

Correction of hyponatremia can be complicated by brisk free water diuresis with a rise in the serum sodium (s-Na) in excess of the generally accepted rate of 10-15 mmol/l/24 hours. We describe this complication and its treatment with desmopressin (dD-AVP), in a 56-year-old female with severe hyponatremia secondary to polydipsia and antidiuretic (ADH) activity. The patient developed a large free water diuresis with a markedly dilute urine (urine osmolality 61 mmol/kg) and a rise in the serum sodium of 19 mmol/l in 19 hours despite the addition of large volumes of free water intravenously and orally. To reduce the free water excretion, desmopressin (dD-AVP) 8 microg was given intravenously. This resulted in a rise in the urinary osmolality, a reduction in the urine volume, and a 2 mmol/l reduction in the serum sodium. Thereafter, the serum sodium rose 4 mmol/l in 24 hours. There were no neurological sequellae. In cases of appropriate but rapid correction of hyponatremia secondary to rapid free water diuresis, dD-AVP can safely reduce the free water excretion, slow the rate of correction of the serum sodium and simplify the fluid therapy of the patient.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749304

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

1.  100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy.

Authors:  Michael L Moritz; Juan Carlos Ayus
Journal:  Metab Brain Dis       Date:  2010-03-11       Impact factor: 3.584

2.  DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.

Authors:  Anjana Perianayagam; Richard H Sterns; Stephen M Silver; Marvin Grieff; Robert Mayo; John Hix; Ruth Kouides
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

3.  Use of desmopressin acetate in severe hyponatremia in the intensive care unit.

Authors:  Cédric Rafat; Frédérique Schortgen; Stéphane Gaudry; Fabrice Bertrand; Romain Miguel-Montanes; Vincent Labbé; Jean-Damien Ricard; David Hajage; Didier Dreyfuss
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 8.237

4.  The Role of Desmopressin in the Management of Severe, Hypovolemic Hyponatremia: A Single-Center, Comparative Analysis.

Authors:  Frank L Ward; Sheldon W Tobe; David M J Naimark
Journal:  Can J Kidney Health Dis       Date:  2018-03-21

Review 5.  New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children.

Authors:  Michael L Moritz; Juan Carlos Ayus
Journal:  Pediatr Nephrol       Date:  2009-11-06       Impact factor: 3.714

Review 6.  Use of Desmopressin in Hyponatremia: Foe and Friend.

Authors:  Steven G Achinger; Juan Carlos Ayus
Journal:  Kidney Med       Date:  2019-03-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.